Welcome, Guest. Please login or register.
May 06, 2021, 02:04:55 am

Login with username, password and session length


Members
Stats
  • Total Posts: 759540
  • Total Topics: 64404
  • Online Today: 249
  • Online Ever: 4912
  • (November 13, 2019, 02:56:14 am)
Users Online
Users: 0
Guests: 225
Total: 225

Welcome


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Do I Have HIV?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Concerns Arise Over Blood Donated by People on Antiretrovirals  (Read 708 times)

0 Members and 1 Guest are viewing this topic.

Offline Jim Allen

  • Administrator
  • Member
  • Posts: 17,040
  • Twitter @JimAllenDublin
    • HIV Lessons
 :o I had to read this three times...

https://www.poz.com/article/concerns-arise-blood-donated-people-antiretrovirals

Quote
Given that a small number of people donating blood in the United States are taking antiretrovirals (ARVs), researchers have expressed concern that such medication use, whether as HIV treatment or pre-exposure prophylaxis (PrEP), could mask the presence of HIV and allow the virus into the blood supply, Healio reports.

Publishing their findings in the journal Blood, Custer and his colleagues conducted blind testing for ARVs in blood donation samples drawn from a group of individuals identified as having HIV through routine blood-donation screening and another group of donors who tested negative for the virus through screening. The researchers also screened samples from the blood donations of HIV-negative men 18 to 45 years old who gave blood at six U.S. locations, testing for the presence of the two components of Truvada (tenofovir disoproxil fumarate/emtricitabine), the first drug approved for use as PrEP.

Among the 300 samples from HIV-negative people that were tested for the presence of ARVs, no such medications were detected. However, 46 (15%) of the samples from the HIV-positive individuals showed evidence of ARVs. Of those samples, 94% came from people who were donating blood for the first time, and 74% were from men.

Custer and his colleagues are concerned that if blood donations come from people with HIV who are taking ARVs or people who have recently taken PrEP and yet contracted the virus, the ARVs in their bloodstream could suppress the virus such that the HIV testing used to screen the blood supply could fail to detect the virus’s presence. Furthermore, it remains at least theoretically possible that such a blood donation could transmit the virus to its recipient.

“Persons who are HIV positive and taking [ARV treatment] and persons taking PrEP to prevent HIV infection are donating blood,” the study authors concluded. “Both situations could lead to increased risk of HIV transfusion transmission if blood screening assays are unable to detect HIV in donations from infected donors.

https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2020006890/461293/HIV-antiretroviral-therapy-and-prevention-use-in

Quote
Objectives: Three different ART/PrEP prevalence analyses in blood donors were conducted.

Methods: First, blood samples from HIV-positive and a comparison group of infection-nonreactive donors were tested under blind using liquid chromatography-tandem mass spectrometry for ART.

Second, blood donor samples from infection-nonreactive, 18-45 year-old, male, first-time blood donors in six US locations were tested for emtricitabine and tenofovir.

Third, in men who have sex with men (MSM) participating in the 2017 CDC National HIV Behavioral Surveillance (NHBS) from five US cities self-reported PrEP use proximate to donation was assessed.

Findings: In blind testing, no ART was detected in 300 infection-nonreactive donor samples, but in 299 HIV-confirmed infected donor samples, 46 (15.4%, 95% CI 11.5 - 20.0%) had evidence of ART. Of the 1,494 samples tested from first-time, male donors, 9 (0.6%, 95% CI 0.03 - 1.1%) had tenofovir and emtricitabine.

In the NHBS MSM survey, 27 of 591 respondents (4.8%, 95% CI 3.2 - 6.9%) reported donating blood in 2016 or 2017 and PrEP use within the same time frame as blood donation.

Conclusions: Persons who are HIV-positive and taking ART and persons taking PrEP to prevent HIV infection are donating blood.
HIV 101 - Everything you need to know
HIV 101
Read more about Testing here:
HIV Testing
Read about Treatment-as-Prevention (TasP) here:
HIV TasP
You can read about HIV prevention here:
HIV prevention
Read about PEP and PrEP here
PEP and PrEP

 


Terms of Membership for these forums
 

© 2021 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.